"たけだP" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonShould Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock? - Yahoo Finance
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock? Yahoo Finance
Enantioselective α‐Aminoxylation of Ketones Catalyzed by a Chiral Brønsted Acid - Wiley
Enantioselective α‐Aminoxylation of Ketones Catalyzed by a Chiral Brønsted Acid Wiley
Is Takeda Pharmaceutical (TSE:4502) Pricing Look Compelling After Strong Multi‑Year Share Gains -...
Is Takeda Pharmaceutical (TSE:4502) Pricing Look Compelling After Strong Multi‑Year Share Gains simplywall.st
Takeda trims sales force to navigate patent loss - Новости GxP
Takeda trims sales force to navigate patent loss Новости GxP
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now? - Yahoo Finance
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now? Yahoo Finance
Takeda patent expiry primes Korea P-CAB shake-up, puts Daewon at risk - CHOSUNBIZ - Chosunbiz
Takeda patent expiry primes Korea P-CAB shake-up, puts Daewon at risk - CHOSUNBIZ Chosunbiz
Takeda presents additional Phase 3 clinical insights on investigational TYK2 inhibitor zasocitini...
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, ...
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care – News Hub Medianet News Hub
Takeda’s TAK-861 Shows Promise in Improving Wakefulness in Phase 1 Trial Among Healthy Men - Neur...
Takeda’s TAK-861 Shows Promise in Improving Wakefulness in Phase 1 Trial Among Healthy Men Neurology Live
Iclusig comes too late to rescue Takeda | ApexOnco - Clinical Trials news and analysis - Oncology...
Iclusig comes too late to rescue Takeda | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on t...
Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on the shelf Fierce Biotech
Takeda Reports Strong Phase 3 Results For Zasocitinib In Plaque Psoriasis - BioPharma APAC
Takeda Reports Strong Phase 3 Results For Zasocitinib In Plaque Psoriasis BioPharma APAC
Stock Information & Shareholder Returns - Takeda Pharmaceuticals
Stock Information & Shareholder Returns Takeda Pharmaceuticals
Takeda engaged in antitrust scheme to delay generic constipation drug: US jury - businessinsuranc...
Takeda engaged in antitrust scheme to delay generic constipation drug: US jury businessinsurance.com
Korean pharmas race for generic P-CAB market amid Takeda's uncertain future for Vocinti - koreabi...
Korean pharmas race for generic P-CAB market amid Takeda's uncertain future for Vocinti koreabiomed.com
Takeda G protein–coupled receptor 5 (TGR5): an attractive therapeutic target for aging-related ca...
Scoop: San Diego Biotech Partners with Takeda, Lands $1.2B Milestone Deal - Business San Diego
Scoop: San Diego Biotech Partners with Takeda, Lands $1.2B Milestone Deal Business San Diego
Takeda’s market exit and return of vonoprazan raise stakes in Korea’s drug pricing battle - korea...
Takeda’s market exit and return of vonoprazan raise stakes in Korea’s drug pricing battle koreabiomed.com
Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data d...
Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail Fierce Biotech
Takeda taps Julie Kim as next CEO, 1st Korean American to lead global pharma company - koreabiome...
Takeda taps Julie Kim as next CEO, 1st Korean American to lead global pharma company koreabiomed.com
Takeda Pharmaceutical Company Limited (TAK) Presents at 44th Annual J.P. Morgan Healthcare Confer...
Takeda: Lack Of Realistic Upside In Japanese Pharma (NYSE:TAK) - Seeking Alpha
Takeda: Lack Of Realistic Upside In Japanese Pharma (NYSE:TAK) Seeking Alpha
Takeda Korea names Peter Trang as head of business operations - koreabiomed.com
Takeda Korea names Peter Trang as head of business operations koreabiomed.com
Takeda powers toward pivotal trials after phase 2b narcolepsy win but pauses multi-indication dre...
Takeda powers toward pivotal trials after phase 2b narcolepsy win but pauses multi-indication dream Fierce Biotech
S&P Rates Takeda Pharmaceutical US Unit's Notes BBB+ - Moomoo
Poseida’s $6B blood relationship with Roche akin to Takeda deal in concept, strategy: CEO - BioWo...
Poseida’s $6B blood relationship with Roche akin to Takeda deal in concept, strategy: CEO BioWorld News
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide ...
Anion‐Responsive Colorimetric and Fluorometric Red‐Shift in Triarylborane Derivatives: Dual Role ...
Asian Community Fund to Honor Takeda CEO-elect Julie Kim and MIT Provost Dr. Anantha Chandrakasan...
Asian Community Fund to Honor Takeda CEO-elect Julie Kim and MIT Provost Dr. Anantha Chandrakasan at 2026 Gala INDIA New England News
El Dorado High School recognizes alumnae and Olympians Kelly Claes and Janie Reed Takeda - Placen...
El Dorado High School recognizes alumnae and Olympians Kelly Claes and Janie Reed Takeda Placentia-Yorba Linda Unified School District
Shota Takeda Stats, Age, Position, Height, Weight, Fantasy & News - MLB.com
Shota Takeda Stats, Age, Position, Height, Weight, Fantasy & News MLB.com
Takeda and Okayama lead Japanese surge at Women's Open Championship - news.cgtn.com
Takeda and Okayama lead Japanese surge at Women's Open Championship news.cgtn.com
Pioneering Drug Discovery Company Bridge Medicines Launched to Advance Promising Early Technologi...
Paddington Life Sciences Symposium celebrates the power of collaboration in life sciences - Imper...
Paddington Life Sciences Symposium celebrates the power of collaboration in life sciences Imperial College Healthcare NHS Trust
Fabrication of Ultra-Thin Printed Organic TFT CMOS Logic Circuits Optimized for Low-Voltage Weara...
Zydus inks licensing pact with Takeda to sell GERD drug - The Economic Times
Zydus inks licensing pact with Takeda to sell GERD drug The Economic Times
Takeda, Sanford-Burnham Launch Heart Failure Collaboration - Genetic Engineering and Biotechnolog...
Takeda, Sanford-Burnham Launch Heart Failure Collaboration Genetic Engineering and Biotechnology News
Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India - ETPharma.com
Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India ETPharma.com
Takeda PH promotes equitable access to medicines at SEA Summit - Philippine News Agency
Takeda PH promotes equitable access to medicines at SEA Summit Philippine News Agency
Takeda, Frazier Healthcare Partners to launch Phathom Pharma - BioSpectrum Asia
Takeda, Frazier Healthcare Partners to launch Phathom Pharma BioSpectrum Asia
Takeda Pharmaceutical names Serina Fischer as head of India operations - ETHRWorld.com
Takeda Pharmaceutical names Serina Fischer as head of India operations ETHRWorld.com
Mankind Pharma signs agreement with Takeda to commercialize Vonoprazan in India - Indian Pharma Post
Mankind Pharma signs agreement with Takeda to commercialize Vonoprazan in India Indian Pharma Post
Mankind Pharma inks pact with Takeda to commercialise acidity drug in India - Business Standard
Mankind Pharma inks pact with Takeda to commercialise acidity drug in India Business Standard
Feature Profiles on Plasma Etch of Organic Films by a Temporal Control of Radical Densities and R...
Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India - Business Standard
Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India Business Standard
FTSE 100 rises as Shire shares make gains on new Takeda offer - Irish Independent
FTSE 100 rises as Shire shares make gains on new Takeda offer Irish Independent
Torrent Pharma in pact with Takeda to commercialize acid reflux drug - Mint
Torrent Pharma in pact with Takeda to commercialize acid reflux drug Mint
Zydus ties with Takeda to sell GERD drug - Mint
Torrent pharma inks licensing pact with Takeda to commercialise GERD drug - Zee Business
Torrent pharma inks licensing pact with Takeda to commercialise GERD drug Zee Business